Form 8-K - Current report:
SEC Accession No. 0001140361-25-000943
Filing Date
2025-01-13
Accepted
2025-01-13 16:53:07
Documents
50
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20041481_8k.htm   iXBRL 8-K 41509
2 EXHIBIT 99.1 ef20041481_ex99-1.htm EX-99.1 33901
3 EXHIBIT 99.2 ef20041481_ex99-2.htm EX-99.2 65362
7 ef20041481_ex99-2slide1.jpg GRAPHIC 183278
8 ef20041481_ex99-2slide2.jpg GRAPHIC 402570
9 ef20041481_ex99-2slide3.jpg GRAPHIC 121073
10 ef20041481_ex99-2slide4.jpg GRAPHIC 113589
11 ef20041481_ex99-2slide5.jpg GRAPHIC 103377
12 ef20041481_ex99-2slide6.jpg GRAPHIC 99664
13 ef20041481_ex99-2slide7.jpg GRAPHIC 51347
14 ef20041481_ex99-2slide8.jpg GRAPHIC 161184
15 ef20041481_ex99-2slide9.jpg GRAPHIC 182507
16 ef20041481_ex99-2slide10.jpg GRAPHIC 79936
17 ef20041481_ex99-2slide11.jpg GRAPHIC 100919
18 ef20041481_ex99-2slide12.jpg GRAPHIC 42281
19 ef20041481_ex99-2slide13.jpg GRAPHIC 94189
20 ef20041481_ex99-2slide14.jpg GRAPHIC 251601
21 ef20041481_ex99-2slide15.jpg GRAPHIC 142798
22 ef20041481_ex99-2slide16.jpg GRAPHIC 81684
23 ef20041481_ex99-2slide17.jpg GRAPHIC 168443
24 ef20041481_ex99-2slide18.jpg GRAPHIC 213409
25 ef20041481_ex99-2slide19.jpg GRAPHIC 132278
26 ef20041481_ex99-2slide20.jpg GRAPHIC 133717
27 ef20041481_ex99-2slide21.jpg GRAPHIC 85793
28 ef20041481_ex99-2slide22.jpg GRAPHIC 170053
29 ef20041481_ex99-2slide23.jpg GRAPHIC 133145
30 ef20041481_ex99-2slide24.jpg GRAPHIC 204849
31 ef20041481_ex99-2slide25.jpg GRAPHIC 182160
32 ef20041481_ex99-2slide26.jpg GRAPHIC 149031
33 ef20041481_ex99-2slide27.jpg GRAPHIC 120328
34 ef20041481_ex99-2slide28.jpg GRAPHIC 177479
35 ef20041481_ex99-2slide29.jpg GRAPHIC 175015
36 ef20041481_ex99-2slide30.jpg GRAPHIC 110122
37 ef20041481_ex99-2slide31.jpg GRAPHIC 184789
38 ef20041481_ex99-2slide32.jpg GRAPHIC 58662
39 ef20041481_ex99-2slide33.jpg GRAPHIC 146977
40 ef20041481_ex99-2slide34.jpg GRAPHIC 131232
41 ef20041481_ex99-2slide35.jpg GRAPHIC 107468
  Complete submission text file 0001140361-25-000943.txt   7190745

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bbio-20250113.xsd EX-101.SCH 3986
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20250113_lab.xml EX-101.LAB 21967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20250113_pre.xml EX-101.PRE 16047
53 EXTRACTED XBRL INSTANCE DOCUMENT ef20041481_8k_htm.xml XML 4225
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 25526887
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)